TransMedics Group, Inc. Capital Expenditures Incurred but Not yet Paid
TransMedics Group, Inc. (TMDX) reported Capital Expenditures Incurred but Not yet Paid of $2.91 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2026-08-04
- TransMedics Group, Inc. capital expenditures incurred but not yet paid for the quarter ending 2026-06-30 was $1.81M, a 1638.46% increase year-over-year.
- TransMedics Group, Inc. capital expenditures incurred but not yet paid for the quarter ending 2026-03-31 was $1.10M, a 2.99% decline year-over-year.
- TransMedics Group, Inc. capital expenditures incurred but not yet paid for the quarter ending 2025-12-31 was -$35.00K, a 103.09% decline year-over-year.
- TransMedics Group, Inc. capital expenditures incurred but not yet paid for the quarter ending 2025-09-30 was $548.00K.
- TransMedics Group, Inc. capital expenditures incurred but not yet paid for fiscal 2025 was $1.75M, a 14.99% decline from fiscal 2024.
- TransMedics Group, Inc. capital expenditures incurred but not yet paid for fiscal 2024 was $2.06M, a 15.97% decline from fiscal 2023.
- TransMedics Group, Inc. capital expenditures incurred but not yet paid for fiscal 2023 was $2.45M, a 3858.06% increase from fiscal 2022.
- TransMedics Group, Inc. capital expenditures incurred but not yet paid for fiscal 2022 was $62.00K, a 94.83% decline from fiscal 2021.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 9 month | Capital Expenditures Incurred but Not yet Paid 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $2.91M 10-Q · filed 2026-08-04 | $2.88M derived: sum of 3 quarters · filed 2026-08-04 | $3.42M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $1.10M 10-Q · filed 2026-05-05 | $1.07M derived: sum of 2 quarters · filed 2026-05-05 | $1.61M derived: sum of 3 quarters · filed 2026-05-05 | $1.72M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | -$35.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $513.00K derived: sum of 2 quarters · filed 2026-02-24 | $617.00K derived: sum of 3 quarters · filed 2026-08-04 | $1.75M 10-K · filed 2026-02-24 |
| 2025-09-30 | $548.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $652.00K derived: sum of 2 quarters · filed 2026-08-04 | $1.79M 10-Q · filed 2025-10-29 | $2.92M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $104.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $1.24M 10-Q · filed 2026-08-04 | $2.37M derived: sum of 3 quarters · filed 2026-08-04 | $1.76M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $1.14M 10-Q · filed 2026-05-05 | $2.27M derived: sum of 2 quarters · filed 2026-05-05 | $1.66M derived: sum of 3 quarters · filed 2026-05-05 | $2.02M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $1.13M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $522.00K derived: sum of 2 quarters · filed 2026-02-24 | $882.00K derived: sum of 3 quarters · filed 2026-02-24 | $2.06M 10-K · filed 2026-02-24 |
| 2024-09-30 | -$610.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | -$250.00K derived: sum of 2 quarters · filed 2025-10-29 | $930.00K 10-Q · filed 2025-10-29 | $1.66M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $360.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | $1.54M 10-Q · filed 2025-07-30 | $2.27M derived: sum of 3 quarters · filed 2026-02-24 | $3.92M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | $1.18M 10-Q · filed 2025-05-08 | $1.91M derived: sum of 2 quarters · filed 2026-02-24 | $3.56M derived: sum of 3 quarters · filed 2026-02-24 | $3.60M derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | $730.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $2.38M derived: sum of 2 quarters · filed 2026-02-24 | $2.42M derived: sum of 3 quarters · filed 2026-02-24 | $2.45M 10-K · filed 2026-02-24 |
| 2023-09-30 | $1.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | $1.69M derived: sum of 2 quarters · filed 2024-10-29 | $1.72M 10-Q · filed 2024-10-29 | $860.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $41.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $71.00K 10-Q · filed 2024-08-01 | -$793.00K derived: sum of 3 quarters · filed 2025-02-27 | -$1.19M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $30.00K 10-Q · filed 2024-05-02 | -$834.00K derived: sum of 2 quarters · filed 2025-02-27 | -$1.24M derived: sum of 3 quarters · filed 2025-02-27 | -$847.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | -$864.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$1.26M derived: sum of 2 quarters · filed 2025-02-27 | -$877.00K derived: sum of 3 quarters · filed 2025-02-27 | $62.00K 10-K · filed 2025-02-27 |
| 2022-09-30 | -$401.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$13.00K derived: sum of 2 quarters · filed 2023-11-08 | $926.00K 10-Q · filed 2023-11-08 | $1.78M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $388.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $1.33M 10-Q · filed 2023-08-04 | $2.19M derived: sum of 3 quarters · filed 2024-02-27 | $2.46M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $939.00K 10-Q · filed 2023-05-04 | $1.80M derived: sum of 2 quarters · filed 2024-02-27 | $2.07M derived: sum of 3 quarters · filed 2024-02-27 | $2.13M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $858.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $1.13M derived: sum of 2 quarters · filed 2024-02-27 | $1.19M derived: sum of 3 quarters · filed 2024-02-27 | $1.20M 10-K · filed 2024-02-27 |
| 2021-09-30 | $272.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $335.00K derived: sum of 2 quarters · filed 2022-11-04 | $342.00K 10-Q · filed 2022-11-04 | |
| 2021-06-30 | $63.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $70.00K 10-Q · filed 2022-08-03 | ||
| 2021-03-31 | $7.00K 10-Q · filed 2022-05-05 | |||
| 2020-09-30 | -$21.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$86.00K derived: sum of 2 quarters · filed 2021-11-09 | $26.00K 10-Q · filed 2021-11-09 | $105.00K derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | -$65.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $47.00K 10-Q · filed 2021-08-06 | $126.00K derived: sum of 3 quarters · filed 2021-05-07 | $197.00K derived: sum of 4 quarters · filed 2021-05-07 |
| 2020-03-31 | $112.00K 10-Q · filed 2021-05-07 | $191.00K derived: sum of 2 quarters · filed 2021-05-07 | $262.00K derived: sum of 3 quarters · filed 2021-05-07 | $152.00K derived: sum of 4 quarters · filed 2021-05-07 |
| 2019-12-28 | $79.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $150.00K derived: sum of 2 quarters · filed 2021-03-11 | $40.00K derived: sum of 3 quarters · filed 2021-03-11 | $169.00K 10-K · filed 2021-03-11 |
| 2019-09-28 | $71.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | -$39.00K derived: sum of 2 quarters · filed 2020-08-07 | $90.00K 10-Q · filed 2019-11-08 | |
| 2019-06-29 | -$110.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $19.00K 10-Q · filed 2020-08-07 | ||
| 2019-03-30 | $129.00K 10-Q · filed 2020-05-06 | |||
| 2018-03-31 | $4.00K 10-Q · filed 2019-06-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |